Hepatitis B is an infection that is transmitted from the mother to the infant during birth and affects the liver causing liver inflammation or other liver-related chronic diseases. The transmission of the virus takes place through contact with blood or other body fluids. Hepatitis B vaccines like Engerix-B and Recombivax are the vaccines that prevent Hepatitis B virus infection (HBV) that have been approved by the Food and Drug Administration of the United States. It is a safe and effective vaccine also recognized by WHO that is recommended for infants at birth up to children of 18 years.
This vaccine is also recommended for adults with diabetes and is known as the first anti-cancer vaccine because it prevents hepatitis B that is the leading cause of cancer in the world. Hepatitis B vaccines are given to infants 24 hours after the birth to prevent any kind of infection and then in a series of two, three or four shots over a 4 to 6 months period that depends on various brands of the vaccine. Several vaccine doses are needed in people with poor immune function.
The global hepatitis B vaccines market report analyses the market value of Hepatitis B vaccines. According to the research conducted by the WHO, 27 million people are living with hepatitis B infection while 4.5 million of the diagnosed people were on treatment. The potential increase is forecasted for the period from 2019 to 2025. The increasing risks of liver cancer and cirrhosis and the changing lifestyle of the population is leading to the rise in the global hepatitis B vaccine market.
Top Key Players
LG Life Sciences
Shenzhen Kangtai Biological Products
Global Hepatitis B Vaccines Market Segmentation
Segment by Type
Segment by Application
Geographically, the growth in the global level is escalating and rapidly increasing due to the global recognition and mandatory usage of the hepatitis B vaccine. Regions like North America, Southeast Asia, Europe, and countries like India, China, and Japan are the major centres driving the demand and supply of the hepatitis B vaccine. The process of vaccine development by the key companies and the approval is stringently regulated by the state regulatory authorities globally, leading to a slight negative impact on market growth. The report also showcases the manufacturing sites, capacity, production procedures, ex-factory price, and the market share that points towards the participation of the key players in the global hepatitis B vaccines market.
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349